JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

Search

KKR & Co LP

Abierto

SectorFinanzas

113.23 0.88

Resumen

Variación precio

24h

Actual

Mínimo

111.62

Máximo

114.01

Métricas clave

By Trading Economics

Ingresos

784M

1.4B

Ventas

-1.5B

3.2B

P/B

Media del Sector

29.863

20.525

BPA

1.32

Rentabilidad por dividendo

0.71

Margen de beneficios

43.254

Empleados

4,834

EBITDA

45M

2.5B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+31.54% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.71%

4.36%

Próximas Ganancias

1 may 2025

Próxima Fecha de Ex Dividendo

12 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-26B

95B

Apertura anterior

112.35

Cierre anterior

113.23

Puntuación técnica

By Trading Central

Confianza

Very Strong Bullish Evidence

KKR & Co LP Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

22 abr 2025, 06:50 UTC

Adquisiciones, fusiones, absorciones

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

14 abr 2025, 11:46 UTC

Adquisiciones, fusiones, absorciones

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1 Billion Deal

9 abr 2025, 10:24 UTC

Adquisiciones, fusiones, absorciones

EQT to Sell Karo Healthcare to KKR

9 abr 2025, 07:09 UTC

Adquisiciones, fusiones, absorciones

Assura Accepts $2 Billion Takeover Offer From KKR Consortium

9 abr 2025, 06:02 UTC

Adquisiciones, fusiones, absorciones

KKR Nears $2.85 Billion Deal With EQT For E45 Maker Karo Healthcare, FT Reports, Citing Sources

7 abr 2025, 14:42 UTC

Adquisiciones, fusiones, absorciones

Assura Agrees to Primary Health Properties Bid Deadline Extension

4 abr 2025, 10:15 UTC

Principales Movimientos del Mercado
Adquisiciones, fusiones, absorciones

Gerresheimer Shares Fall After Report That KKR Exited Consortium Seeking Bid

4 abr 2025, 09:39 UTC

Adquisiciones, fusiones, absorciones

KKR Drops Out of Consortium Attempting Gerresheimer Takeover, Bloomberg Says, Citing Sources

3 abr 2025, 14:57 UTC

Adquisiciones, fusiones, absorciones

Primary Health Proposes $1.95 Billion Bid for Assura -- Update

3 abr 2025, 07:17 UTC

Adquisiciones, fusiones, absorciones

Primary Health Proposes $1.95 Billion Bid for Assura

22 abr 2025, 06:04 UTC

Adquisiciones, fusiones, absorciones

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22 abr 2025, 06:03 UTC

Adquisiciones, fusiones, absorciones

KKR: Biotage Board Recommends Shareholders Accept Offer

22 abr 2025, 06:02 UTC

Adquisiciones, fusiones, absorciones

KKR: Offer Values Biotage at SEK11.61B

22 abr 2025, 06:02 UTC

Adquisiciones, fusiones, absorciones

KKR Makes SEK145 a Share Bid For Biotage

18 abr 2025, 00:00 UTC

Principales Noticias

Private Equity World Engulfed by Perfect Storm -- WSJ

14 abr 2025, 11:31 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1B Deal

14 abr 2025, 11:02 UTC

Adquisiciones, fusiones, absorciones

KKR: Making OSTTRA Investment Primarily Through North America Private-Equity Strategy >KKR

14 abr 2025, 11:01 UTC

Adquisiciones, fusiones, absorciones

S&P Global, CME to Divide Sale Proceeds Evenly Pursuant to 50/50 Joint Venture >SPGI CME

14 abr 2025, 11:00 UTC

Adquisiciones, fusiones, absorciones

S&P Global, CME Group to Sell OSTTRA to KKR for $3.1 Billion >SPGI CME KKR

14 abr 2025, 11:00 UTC

Adquisiciones, fusiones, absorciones

S&P Global and CME Group to Sell OSTTRA to KKR for $3.1 Billion

11 abr 2025, 11:56 UTC

Adquisiciones, fusiones, absorciones

KKR Now Owns 30% of Enilive

11 abr 2025, 11:55 UTC

Adquisiciones, fusiones, absorciones

KKR Completes Acquisition of Additional Stake in Enilive

9 abr 2025, 09:51 UTC

Adquisiciones, fusiones, absorciones

EQT to Sell Karo Healthcare to KKR for an Undisclosed Amount

9 abr 2025, 09:32 UTC

Adquisiciones, fusiones, absorciones

EQT: Transaction Expected to Close in Coming Months

9 abr 2025, 09:31 UTC

Adquisiciones, fusiones, absorciones

EQT to Sell Karo Healthcare to KKR

3 abr 2025, 08:17 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Primary Health Properties' Lower Bid for Assura Is a Calculated Risk -- Market Talk

28 mar 2025, 09:34 UTC

Adquisiciones, fusiones, absorciones

Topcon: Tender Offer Expected to Start Around End-July >7732.TO

28 mar 2025, 09:33 UTC

Adquisiciones, fusiones, absorciones

Topcon: CEO Takashi Eto Also Plans to Participate in Tender Offer, Make Reinvestment After Completion of Offer >7732.TO

28 mar 2025, 09:31 UTC

Adquisiciones, fusiones, absorciones

Topcon: JICC Plans to Indirectly Hold Voting Rights in Topcon >7732.TO

28 mar 2025, 09:31 UTC

Adquisiciones, fusiones, absorciones

Topcon: KKR Plans to Indirectly Hold Majority Interest in Topcon >7732.TO

Comparación entre iguales

Cambio de precio

KKR & Co LP previsión

Precio Objetivo

By TipRanks

31.54% repunte

Estimación a 12 Meses

Media 140.5 USD  31.54%

Máximo 194 USD

Mínimo 114 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para KKR & Co LP Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

12 ratings

11

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

101.87 / N/ASoporte y Resistencia

Corto Plazo

Very Strong Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de KKR & Co LP

KKR & Co. Inc. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market, and middle market investments. The firm considers investments in all industries with a focus on software, security, semiconductors, consumer electronics, internet of things (iot), internet, information services, information technology infrastructure, financial technology, network and cyber security architecture, engineering and operations, content, technology and hardware, energy and infrastructure, real estate, services industry with a focus on business services, intelligence, industry-leading franchises and companies in natural resource, containers and packaging, agriculture, airports, ports, forestry, electric utilities, textiles, apparel and luxury goods, household durables, digital media, insurance, brokerage houses, non-durable goods distribution, supermarket retailing, grocery stores, food, beverage, and tobacco, hospitals, entertainment venues and production companies, publishing, printing services, capital goods, financial services, specialized finance, pipelines, and renewable energy. In energy and infrastructure, it focuses on the upstream oil and gas and equipment, minerals and royalties and services verticals. In real estate, the firm seeks to invest in private and public real estate securities including property-level equity, debt and special situations transactions and businesses with significant real estate holdings, and oil and natural gas properties. The firm also invests in asset services sector that encompasses a broad array of B2B, B2C and B2G services verticals including asset-based, transport, logistics, leisure/hospitality, resource and utility support, infra-like, mission-critical, and environmental services. Within Americas, the firm prefers to invest in consumer products; chemicals, metals and m